Primary sclerosing cholangitis in children

Journal of Gastroenterology and Hepatology (Australia)

Volumn 14, Issue 6, 1999, Pages 588-593

  Roberts, Eve A ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Autoimmune hepatitis; Children; Hepatobiliary disease; Primary sclerosing cholangitis

Indexed keywords

ADOLESCENT; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; BILE DUCT; BILIARY CIRRHOSIS; CHILD; CHILDHOOD DISEASE; CHOLANGIOGRAPHY; CHOLESTASIS; CONGENITAL DISORDER; CYSTIC FIBROSIS; FEMALE; HISTIOCYTOSIS; HUMAN; INTRAHEPATIC BILE DUCT; LIVER TRANSPLANTATION; MALE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL;

EID: 0033014976     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.1999.01919.x     Document Type: Article

References (56)

1. 1 Wilschanski M, Chait P, Wade JA et al. Primary sclerosing cholangitis in 32 children: Clinical, laboratory and radiographic features, with survival analysis. Hepatology 1995; 22: 1415-22.
2. 2 El-Shabrawi M, Wilkinson M, Portmann B et al. Primary sclerosing cholangitis in childhood. Gastroenterology 1987; 92: 1226-35.
3. 3 Gregorio GV, Karani J, Portmann B, Vergani D, Mieli-Vergani G. Sclerosing cholangitis in childhood: A 17 year experience (abstract). Hepatology 1996; 24: 171A.
4. 4 Chapman RWG, Arborgh BAM, Rhodes JM et al. Primary sclerosing cholangitis, a review of its clinical features. Gut 1980; 21: 870-7.
5. 5 Sokal EM, Ville de Goyet J, Buts JP et al. Unifocal stricture of the common bile duct in two children: A localized form of primary sclerosing cholangitis. J. Pediatr. Gastroenterol. Nutr. 1990; 11: 268-74.
6. 6 Bansi DS, Fleming KA, Chapman RW. Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: Prevalence, titre and IgG subclass. Gut 1996; 38: 384-9.
7. 7 Hardarson S, Labrecque DR, Mitros FA, Neil GA, Gocken JA. Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases. High prevalence in ulcerative colitis, primary sclerosing cholangitis and autoimmune hepatitis. Am. J. Clin. Pathol. 1993; 99: 277-81.
8. 8 Claise C, Johanet C, Bouhnik Y, Kapel N, Homberg J-C, Poupon R. Antineutrophil cytoplasmic autoantibodies in autoimmune liver and inflammatory bowel disease. Liver 1996; 16: 28-34.
9. 9 Lo SK, Chapman RWG, Cheeseman P et al. Antineutrophil antibody: A test for autoimmune primary sclerosing cholangitis in childhood. Gut 1993; 34: 199-202.
10. 10 Chapman RW, Varzhesc Z, Gaul R, Patel G, Kokinon N, Sherlock S. Association of primary sclerosing cholangitis with HLA B8. Gut 1983; 24: 38-41.
11. 11 Donaldson PT, Farrant JM, Wilkinson ML, Hayliar K, Portmann BC, Williams R. Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis. Hepatology 1991; 13: 129-33.
12. 12 Mehal WZ, Lo YM, Wordsworth BP et al. HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis. Gastroenterology 1994; 106: 160-7.
13. 13 Olerup O, Olsson R, Hulterantz R, Broome U. HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis. Gastroenterology 1995; 108: 870-8.
14. 14 Isoyama K, Yamada K, Ishikawa K, Sanada Y. Coincidental cases of primary sclerosing cholangitis and biliary atresia in siblings? Acta Paediatr. 1995; 84: 1444-6.
15. 15 Minuk GY, Sutherland LR, Pappas SC, Kelly JK, Martin SE. Autoimmune chronic active hepatitis (lupoid hepatitis) and primary sclerosing cholangitis in two young adult females. Can. J. Gastroenterol. 1988; 2: 22-7.
16. 16 Rabinovitz M, Demetris AJ, Bou-Abboud CF, VanThiel DH. Simultaneous occurrence of primary sclerosing cholangitis and autoimmune chronic active hepatitis in a patient with ulcerative colitis. Dig. Dis. Sci. 1992; 37: 1606-11.
17. 17 Maggiore G, Veber F, Bernard O et al. Autoimmune hepatitis associated with anti-actin antibodies in children and adolescents. J. Pediatr. Gastroenterol. Nutr. 1993; 17: 376-81.
18. 18 Lawrence SP, Sherman KE, Lawson JM, Goodman ZD. A 39 year old man with chronic hepatitis. Semin. Liver Dis. 1994; 14: 97-105.
19. 19 Czaja AJ.The variant forms of autoimmune hepatitis. Ann. Intern. Med. 1996; 125: 588-98.
20. 20 Gilmour SM, Chait P, Phillips MJ, Roberts EA. Ulcerative colitis, autoimmune hemolytic anemia and primary sclerosing cholangitis in a child. Can. J. Gastroenterol. 1996; 10: 301-3.
21. 21 Gohlke F, Lohse AW, Dienes HP et al. Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis. J. Hepatol. 1996; 24: 699-705.
22. 22 McNair ANB, Moloney M, Portmann BC, Williams R, McFarlane IG. Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases. Am. J. Gastroenterol. 1998; 93: 777-84.
23. 23 Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993; 18; 998-1005.
24. 24 Boberg KM, Fausa O, Haaland T et al. Features of autoimmune hepatitis in primary sclerosing cholangitis: An evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis. Hepatology 1996; 23: 1369-76.
25. 25 Mieli-Vergani G, Lobo-Yeo A, McFarlane BM, McFarlane IG, Mowat AP, Vergani D. Different immune mechanisms lead to autoimmunity in primary sclerosing cholangitis and autoimmune chronic active hepatitis of childhood. Hepatology 1989; 9: 198-203.
26. 26 Gregorio GV, Davies ET, Mieli-Vergani G, Vergani D. Significance of extractable nuclear antigens in childhood autoimmune liver disease. Clin. Exp. Immunol. 1995; 102: 308-13.
27. 27 Han S,Tredger M, Gregorio GV, Mieli-Vergani G, Vergani D. Anti-liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease. Hepatology 1995; 21: 58-62.
28. 28 Debray D, Pariente D, Urvoas E, Hadchouel M, Bernard O. Sclerosing cholangitis in children. J. Pediatr. 1994; 124: 49-56.
29. 29 Dickson ER, Murtaugh PA, Wiesner RH et al. Primary sclerosing cholangitis: Refinement and validation of survival models. Gastroenterology 1992; 103: 1893-901.
30. 30 Broome U, Olsson R, Loof L et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996; 38: 610-15.
31. 31 Mitchell SA, Chapman RW. Review article: The management of primary sclerosing cholangitis. Aliment. Pharmacol. Ther. 1997; 11: 33-43.
32. 32 Beuers U, Spengler U, Kruis W et al. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: A placebo-controlled trial. Hepatology 1992; 16: 707-14.
33. 33 Stiehl A, Rudolph G, Sauer P et al. Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study. J. Hepatol. 1997; 26: 560-6.
34. 34 Lindor KD, Mayo PSC-UDCA Study Group. Ursodiol for primary sclerosing cholangitis. N. Engl. J. Med. 1997; 336: 691-5.
35. 35 Narumi S, Roberts JP, Emond JC, Lake J, Ascher NL. Liver transplantation for sclerosing cholangitis. Hepatology 1995; 22; 451-7.
36. 36 Goss JA, Shackleton CR, Farmer DG et al. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann. Surg. 1997; 225: 472-81.
37. 37 Risdall RJ, Dehner LP, Duray P, Kobrinsky N, Robinson L, Nesbit ME. Histiocytosis X (Langerhans' cell histiocytosis). Arch. Pathol. Lab. Med. 1983; 107: 59-63.
38. 38 Egeler RM, Schipper MEI, Heymanns HSA. Gastrointestinal involvement in Langerhans' cell histiocytosis (histiocytosis X): A clinical report of three cases. Eur. J. Pediatr. 1990; 149: 325-9.
39. 39 Leblanc A, Hadchouel M, Jehan P, Odievre M, Alagille D. Obstructive jaundice in children with histiocytosis X. Gastroenterology 1981; 80: 134-9.
40. 40 Sisto A, Feldman P, Garel L et al. Primary sclerosing cholangitis in children: Study of five cases and review of the literature. Pediatrics 1987; 80: 918-23.
41. 41 Neveu I, Labrune P, Huguet P, Musset D, Chaussain JL, Odievre M. Cholangite sclerosante revelatrice d'une histiocytose X [sclerosing cholangitis revealing histiocytosis X]. Arch. Fr. Pédiatr. 1990; 47: 197-9.
42. 42 Ramos FJ, Perez-Arellano JL, Lopez-Borrasca A. Primary sclerosing cholangitis in histiocytosis X. Am. J. Med. 1987; 82: 191.
43. 43 Thompson H, Pitt HA, Lewin KJ, Longmire WP. Sclerosing cholangitis and histiocytosis X. Gut 1984; 25: 526-30.
44. 44 Rand EB, Whitington PF. Successful orthotopic liver transplantation in two patients with liver failure due to sclerosing cholangitis with Langerhans cell histiocytosis. J. Pediatr. Gastroenterol. Nutr. 1992; 15: 202-7.
45. 45 Zandi P, Panis Y, Debray D, Bernard O, Houssin D. Pediatric liver transplantation for Langerhans' cell histiocytosis. Hepatology 1995; 21: 129-33.
46. 46 Strandvik B, Hjelte L, Gabrielsson H, Glaumann H. Sclerosing cholangitis in cystic fibrosis. Scand. J. Gastroenterol. 1988; 23 (Suppl. 143): 121-4.
47. 47 Nagel RA, Westaby D, Javaid A et al. Liver disease and bile duct abnormalities in adults with cystic fibrosis. Lancet 1989; ii: 1422-5.
48. 48 O'Brien S, Keogan M, Casey M et al. Biliary complications of cystic fibrosis. Gut 1992; 33: 387-91.
49. 49 Waters DL, Dorney SF, Gruca MA et al. Hepatobiliary disease in cystic fibrosis patients with pancreatic sufficiency. Hepatology 1995; 21: 963-9.
50. 50 Neuhaus TJ, Stallmach T, Leumann E, Altorfer J, Braegger CP. Familial progressive tubulo-interstitial nephropathy and cholestatic liver disease: A newly recognized entity? Eur. J. Pediatr. 1997; 156: 723-6.
51. 51 Ichikawa N, Taniguchi A, Akama H et al. Sclerosing cholangitis associated with hypereosinophilic syndrome. Intern. Med. 1997; 36: 561-4.
52. 52 Grauer L, Padilla III VM, Bouza L, Barkin JS. Eosinophilic sclerosing cholangitis associated with hypereosinophilic syndrome. Am. J. Gastroenterol. 1993; 88: 1764-9.
53. 53 Amedée-Manesme O, Bernard O, Brunelle F et al. Sclerosing cholangitis with neonatal onset. J. Pediatr. 1987; 111: 225-9.
54. 54 Maggiore G, De Giacomo C, Ugazio AG. Sclerosing cholangitis in childhood. Gastroenterology 1988; 94: 551-2.
55. 55 Mulberg AE, Arora S, Grand RJ, Vinton N. Expanding the spectrum of neonatal cholestatic liver disease (abstract). Hepatology 1992; 16: 192A.
56. 56 Baker AJ, Portmann B, Westaby D, Wilkinson M, Karani J, Mowat AP. Neonatal sclerosing cholangitis in two siblings: A category of progressive intrahepatic cholestasis. J. Pediatr. Gastroenterol. Nutr. 1993; 17: 317-22.